These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27708496)

  • 1. Value of Positron Emission Tomography/Computed Tomography (PET-CT) in Suspected Non-small Cell Lung Cancer Recurrence and Impact on Patient Management.
    Beslic N; Sadija A; Ceric T; Milardovic R; Ceric S; Cavaljuga S
    Acta Inform Med; 2016 Jul; 24(4):296-298. PubMed ID: 27708496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
    Keidar Z; Haim N; Guralnik L; Wollner M; Bar-Shalom R; Ben-Nun A; Israel O
    J Nucl Med; 2004 Oct; 45(10):1640-6. PubMed ID: 15471827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of recurrence of non-small cell lung cancer after therapy using CT and Integrated PET/CT.
    Opoka L; Szołkowska M; Podgajny Z; Kunikowska J; Barańska I; Błasińska-Przerwa K; Jakubowska L; Rudziński P; Bestry I; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2013; 81(3):214-20. PubMed ID: 23609428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.
    Nasu K; Abe W; Takai N; Tomonari K; Narahara H
    Arch Gynecol Obstet; 2011 May; 283(5):1121-6. PubMed ID: 20574659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography in the management of documented or suspected recurrent ovarian cancer.
    Chou HH; Chen CY; Liu FY; Lin G; Wang CC; Yang LY; Chen MY; Pan YB; Wu RC; Yen TC; Chang TC; Lai CH
    J Formos Med Assoc; 2017 Nov; 116(11):869-879. PubMed ID: 28089190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.
    Kalff V; Hicks RJ; MacManus MP; Binns DS; McKenzie AF; Ware RE; Hogg A; Ball DL
    J Clin Oncol; 2001 Jan; 19(1):111-8. PubMed ID: 11134203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT.
    Jiménez-Bonilla JF; Quirce R; Martínez-Rodríguez I; Banzo I; Rubio-Vassallo AS; Del Castillo-Matos R; Ortega-Nava F; Martínez-Amador N; Ibáñez-Bravo S; Carril JM
    Lung Cancer; 2013 Jul; 81(1):71-6. PubMed ID: 23597930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does positron emission tomography/computed tomography change management in colorectal cancer?
    Falconer R; Connor S; Balasingam A; Eglinton T
    ANZ J Surg; 2018 Apr; 88(4):E248-E251. PubMed ID: 27788564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.
    Hicks RJ; Kalff V; MacManus MP; Ware RE; McKenzie AF; Matthews JP; Ball DL
    J Nucl Med; 2001 Nov; 42(11):1605-13. PubMed ID: 11696628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer.
    Choi SH; Kim YT; Kim SK; Kang KW; Goo JM; Kang CH; Kim JH
    Ann Thorac Surg; 2011 Nov; 92(5):1826-32; discussion 1832. PubMed ID: 22051278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
    Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
    JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Impact of Positron Emission Tomography-Computed Tomography Versus Computed Tomography Alone for High-risk Volume Selection in Head and Neck and Lung Patients Undergoing Radiotherapy: Interim Findings.
    Davis CA; Thomas C; Abdolell M; Day A; Hollenhorst H; Rajaraman M; Mulroy L; Bowes D; Cwajna S; Rheaume D; Patil N; Burrell S; Wilke D
    J Med Imaging Radiat Sci; 2015 Jun; 46(2):148-155. PubMed ID: 31052088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography-computed tomography: a superior and one-stop shop modality for treated head and neck carcinoma compared with conventional tomography.
    Ichpujani VK; Rao SA; Chaturvedi AK; Dewan AK; Choudhary PS
    J Oral Maxillofac Surg; 2014 Nov; 72(11):2319-32. PubMed ID: 25438279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.